Delay expression of NKp30 on NK cells correlates with long-term mycophenolate mofetil treatment and higher EBV viremia post allogenic hematological stem cells transplantation

Copyright © 2019 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 205(2019) vom: 01. Aug., Seite 49-56
1. Verfasser: Yu, Xing-Xing (VerfasserIn)
Weitere Verfasser: Cao, Xun-Hong, Yan, Hong, Luo, Xue-Yi, Zhao, Xiao-Su, Sun, Yu-Qian, Wang, Yu, Xu, Lan-Ping, Zhang, Xiao-Hui, Chang, Ying-Jun, Huang, Xiao-Jun, Zhao, Xiang-Yu
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Allo-HSCT MMF NK cells NKp30 Reconstitution Immunosuppressive Agents NCR3 protein, human Natural Cytotoxicity Triggering Receptor 3 mehr... Mycophenolic Acid HU9DX48N0T
Beschreibung
Zusammenfassung:Copyright © 2019 Elsevier Inc. All rights reserved.
Mycophenolate mofetil (MMF) is an immunosuppressive agent that is widely used in graft-versus-host disease prophylaxis because of its inhibitory function on T cells and B cells. However, the effect of MMF on natural killer cell reconstitution after allogenic hematological transplantation is largely unknown. The present study examined the effects of different MMF administration durations after haploidentical allo-HSCT on NK cell reconstitution. Ninety patients were enrolled in this study and defined into two groups in term of MMF duration. We found that MMF patients in the long-term MMF group were associated with a poor reconstitution of NK cells and a significantly lower cytotoxicity from day 30 to day 180 post-transplantation. Especially, the long-term MMF group inhibits reconstitution of NKp30 NK subsets, which correlated with higher risk of EBV viremia. Multivariate analysis showed that a better reconstitution of NKp30 cells was associated with lower EBV viremia (HR0.957, p = .04). In vitro experiments demonstrated that the active metabolite of MMF, mycophenolic acid (MPA), inhibited the proliferation and cytotoxicity of NK cells from healthy donors or patients at day 30 post-transplantation. In summary, our findings demonstrated that long-term MMF administration delayed the quality and quantity of NK cells, especially NKp30 subpopulations, which was associated with decreased EBV viremia post allogeneic HSCT
Beschreibung:Date Completed 20.04.2020
Date Revised 20.04.2020
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2019.05.010